NGM Biopharmaceuticals, Inc. NGM
1.54 +1.54
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -155.88M | -221.58M | -198.58M | -191.20M | -152.88M | |
| -142.38M | -162.67M | -120.33M | -102.49M | -42.80M | |
| -1.73 | -2.03 | -1.56 | -1.50 | -0.85 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 61.27M | 77.41M | 153.29M | 148.52M | 247.47M | |
| 168.87M | 307.40M | 402.39M | 329.04M | 380.40M | |
| 20.23M | 47.84M | 66.74M | 49.00M | 49.68M | |
| 148.64M | 259.56M | 335.65M | 280.04M | 330.72M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -132.20M | -144.44M | -73.23M | -83.50M | -41.17M | |
| 114.29M | 14.32M | -71.65M | -51.00M | 48.72M | |
| 1.77M | 54.23M | 149.66M | 35.54M | 180.75M | |
| -1.25M | -1.86M | -1.68M | -1.88M | -3.49M | |
| -16.14M | -75.88M | 4.78M | -98.96M | 188.30M |